$310.5 M

KIN Mkt cap, 10-Jun-2019
Kindred Biosciences Net income (Q2, 2019)-14.3 M
Kindred Biosciences EBIT (Q2, 2019)-14.7 M
Kindred Biosciences Cash, 30-Jun-201932 M

Kindred Biosciences Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

R&D expense

19.4m13.9m17.7m26.4m

General and administrative expense

7.9m8.3m14.0m26.5m

Operating expense total

27.3m22.8m31.7m53.2m

EBIT

(27.3m)(22.8m)(31.7m)(51.3m)

Interest income

132.0k325.0k774.0k1.6m

Net Income

(120.0k)(27.1m)(22.5m)(30.9m)(49.7m)

Kindred Biosciences Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

13.0m20.0m6.7m34.8m56.3m

Accounts Receivable

903.0k

Inventories

1.9m1.8m3.6m

Current Assets

101.5m73.8m58.0m81.8m80.1m

PP&E

394.0k1.2m2.4m7.5m26.3m

Total Assets

101.9m79.6m61.6m90.8m106.5m

Accounts Payable

420.0k717.0k410.0k1.4m3.6m

Current Liabilities

2.9m3.2m3.9m6.0m15.2m

Total Liabilities

3.9m6.1m15.3m

Additional Paid-in Capital

130.5m135.0m138.8m196.7m252.9m

Retained Earnings

(31.5m)(58.6m)(81.1m)(112.0m)(161.7m)

Total Equity

76.4m57.7m84.7m91.2m

Financial Leverage

1 x1.1 x1.1 x1.2 x

Kindred Biosciences Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(120.0k)(27.1m)(5.8m)(30.9m)(49.7m)

Depreciation and Amortization

146.0k155.0k475.0k805.0k

Accounts Receivable

(903.0k)

Inventories

(14.1m)16.0m(37.9m)(3.6m)

Accounts Payable

6.0k30.0k(710.0k)1.3m277.0k

Cash From Operating Activities

(62.0k)(22.8m)(18.8m)(21.9m)(45.0m)

Purchases of PP&E

(729.0k)(952.0k)(5.9m)(13.9m)

Cash From Investing Activities

29.4m5.3m(2.7m)16.6m

Cash From Financing Activities

1.0m343.0k162.0k52.7m49.9m

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(6.9m)(7.1m)(6.1m)(11.0m)(16.7m)(6.5m)(13.3m)(21.1m)(10.0m)(21.2m)(34.2m)(16.1m)(30.4m)

Depreciation and Amortization

75.0k115.0k46.0k162.0k295.0k144.0k324.0k527.0k500.0k1.1m

Accounts Receivable

2.1m(242.0k)628.0k(34.0k)

Inventories

(2.5m)(955.0k)(788.0k)

Accounts Payable

347.0k1.1m285.0k567.0k(221.0k)141.0k726.0k515.0k340.0k(1.2m)(2.5m)(60.0k)(1.6m)909.0k

Cash From Operating Activities

(10.6m)(14.3m)(5.9m)(11.4m)(16.1m)(11.2m)(19.8m)(32.2m)(18.7m)(31.8m)

Purchases of PP&E

(832.0k)(838.0k)(332.0k)(902.0k)(4.7m)(409.0k)(2.4m)(8.5m)(2.7m)(6.7m)

Cash From Investing Activities

6.5m7.5m2.4m12.4m525.0k21.0m21.1m17.9m(12.3m)(36.4m)

Cash From Financing Activities

90.0k90.0k16.6m29.2m52.5m(82.0k)49.3m49.4m43.3m43.8m

Kindred Biosciences Ratios

USDY, 2019

Financial Leverage

1.1 x

Kindred Biosciences Employee Rating

3.18 votes
Culture & Values
3.0
Work/Life Balance
2.6
Senior Management
3.1
Salary & Benefits
3.0
Career Opportunities
3.2
Source